Investor Stem Cell Declares 2011 Stem Cell Leaders


This year's principal leaders in the sector are as follows: Geron Corporation (NASDAQ;GERN), Advanced Cell Technology (OTC:ACTC), International Stem Cell Corp. (OTC:ISCO), Pluristem Therapeutics Ltd. (Nasdaq:PSTI), Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA), Mesoblast limited (ASX:MSB) Pfizer Inc. (Public, NYSE:PFE) and Novartis AG (ADR) (Public, NYSE:NVS).



Online PR News – 17-May-2011 –The emerging regenerative medicine sector is heating up. Investor Stem Cell (www.investorstemcell.com) is the world’s only online discussion forum dedicated to regenerative medicine bringing investors and stakeholders together.

Advanced Cell Technology (OTC:ACTC) Currently has two FDA approved trials using (RPE) cells derived from human embryonic stem cells to treat age related macular degeneration and juvenile MD. Issued patent for non-destructive method of harnessing stem cells without destroying the human embryo.

Geron Corporation (NASDAQ;GERN) Geron is the regenerative sector research Goliath. They are the first company approved by the FDA to use (hESC) to derive its drug GRNOP-1 to treat spinal cord injury. Pipeline of stem cell research consist of cancer, cardio and vascular disease.

continue....

http://www.onlineprnews.com/news/139...l-leaders.html